Purchase Order 75F40122P00158

Waters Technologies Corporation was awarded a $191,081.72 firm fixed-price purchase order by the Food and Drug Administration on June 22, 2022, for analytical detectors, quadrupole mass spectrometers, and associated service maintenance agreements. The contract extends through June 30, 2027, with performance taking place at Waters' facility in Milford, Massachusetts. This award represents a direct procurement of specialized analytical instrumentation critical to FDA's regulatory testing and scientific missions, leveraging Waters' established expertise as a leading global manufacturer of advanced laboratory equipment. No small business set-aside designation was applied to this award, reflecting Waters' competitive position in providing highly specialized scientific equipment to federal agencies.

Waters Technologies Corporation, a subsidiary of Waters Corporation, has established itself as a preferred supplier to the FDA and multiple federal agencies through its provision of liquid chromatography systems, mass spectrometry instruments, and comprehensive maintenance services. The company holds significant indefinite delivery/indefinite quantity vehicles, including a $5 million blanket purchase agreement with the Environmental Protection Agency and substantial agreements with the National Institutes of Health and Department of Agriculture, demonstrating its capacity to support critical federal research and regulatory operations. This FDA purchase order for analytical detectors and mass spectrometry equipment with maintenance support aligns with Waters' core business of delivering and sustaining sophisticated analytical instrumentation across the federal government.